Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation
By M. Nakaya, Yichuan Xiao, Jae-Hoon Chang, Mikyoung Chang, Xuhong Cheng, M. Blonska, Xin Lin, Shao-Cong Sun. Immunity, 2014
786 citations recorded by the source corpus.
Glutamine has been implicated as an immunomodulatory nutrient, but how glutamine uptake is mediated during T-cell activation is poorly understood. We have shown that naïve T-cell activation is coupled with rapid glutamine uptake, which depended on the amino acid transporter ASCT2. ASCT2 deficiency impaired the induction of T helper-1 (Th1) and Th17 cells and attenuated inflammatory T-cell responses in mouse models of immunity and autoimmunity. Mechanistically, ASCT2 was required for T cell receptor (TCR)-stimulated activation of the metabolic kinase mTORC1. We have further shown that TCR-stimulated glutamine uptake and mTORC1 activation also required a TCR signaling complex composed of the scaffold protein CARMA1, the adaptor molecule BCL10, and the paracaspase MALT1. This function was independent of IKK kinase, a major downstream target of the CARMA1 complex. These findings highlight a mechanism of T-cell activation involving ASCT2-dependent integration of the TCR signal and a metabolic signaling pathway.
Subfields: Biochemistry, Cancer Research, Immunology
View Paper: https://www.semanticscholar.org/paper/b57edbb5206d7084aa26a3bafcd89cd27922e33e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biochemistry
In Cancer Research
In Immunology
- Erika L. Pearce
- Michael D. Buck
- David O’Sullivan
- Russell G. Jones
- J. Rathmell
- G. V. D. van der Windt
- C. Piccirillo
- S. Kaech
Citations in the corpus
- T cell metabolism drives immunity (2015, background): “It was recently found that loss of ASCT2 decreased glutamine import and impaired OXPHOS and glucose metabolism in activated CD4 T cells (Nakaya et al., 2014).”
- The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight (2019, background): “Additionally, DNA methylation analysis revealed epigenetic discordance (indicated by JSD peaks) for TW in the promoters of NOTCH3, a wellknown regulator of T cell differentiation (34), and SLC1A5/ASCT2, which promotes T cell activation (35), between preflight (L−162) and inflight samples (FD259 forN”
- The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo. (2015, background): “Upon activation, naive T cells shift to- ward a pro-growth metabolic program characterized by increased glucose and amino acid metabolism (Carr et al., 2010; Frauwirth et al., 2002; Nakaya et al., 2014; Sinclair et al., 2013; Wang et al., 2011).”
- Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy. (2020, background): “Additionally, genetic loss of the glutamine transporter protein ASCT2 in T cells resulted in impaired generation and function of Th1 and Th17 cells, whereas Tregs were not altered (Nakaya et al., 2014).”